News Sanofi cuts price of Lantus insulin in US by 78% Pharma joins Eli Lilly, Novo Nordisk as it slashes the price of its widely-prescribed insulins.
News Sanofi buys Provention and diabetes drug Tzield for $2.9bn T1D prevention drug has been tipped as a blockbuster, boosting Sanofi's diabetes franchise.
News Sanofi sings a song for rare disease and equitable care 'This is Rare' campaign sings the plight of the rare disease community this awareness day.
News Sanofi boosts ‘connected insulin’ push with Glooko deal The alliance will pair Glooko's digital health platform with Sanofi's SoloSmart insulin device.
News Sanofi gets FDA nod for long-acting haemophilia A drug Once-weekly Altuviiio could be potential $2 billion-plus blockbuster, according to analysts.
News Reed pops up at J&J after leaving Sanofi Straight after John Reed's Sanofi exit, he has reappeared as head of pharma R&D at J&J
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
